Jhaveri, K. L., Montero, A. J., Italiano, A., Giordano, A., Patnaik, A., Daniele, G., Ahnert, J. R., Munster, P. N., Curigliano, G., Manich, C. S., Duffy, A. G., Wesolowski, R., Arcilla, J. B., Ray-Coquard, I. L., Page, D. B., Muller, A. E. S., Hal, G. V., Du, L., Ashki, N., Juric, D. (2026). A phase 1/2 trial of tersolisib (LY4064809/STX-478), a pan-mutant-selective PI3Kα inhibitor (PI3Kαi), in PIK3CA -mutant advanced solid tumors: Updated results from PIKALO-1.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.1072